Continuous oral levonorgestrel/ethinyl estradiol for treating premenstrual dysphoric disorder

Authors:
  • GGGary S. Grubb
    Gary S. Grubb
  • LSLynne Smith
    Lynne Smith
  • SMSebastian Mirkin
    Sebastian Mirkin
  • GCGinger D. Constantine
    Ginger D. Constantine

Abstract
No abstract available
Funding Information
  • GlaxoSmithKline
  • Stanley Center for Peace and Security
  • Bayer HealthCare
  • Bristol-Myers Squibb
  • National Institutes of Health
  • Forest Laboratories
  • National Institute of Mental Health
  • Pfizer
  • Pfizer
  • National Institute on Aging

This publication has 12 references indexed in Scilit: